ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $422,000 | +97.2% | 50,400 | +63.1% | 0.57% | +57.2% |
| Q4 2016 | $214,000 | +52.9% | 30,900 | -30.2% | 0.36% | +2916.7% |
| Q3 2015 | $140,000 | -51.9% | 44,300 | -54.0% | 0.01% | -50.0% |
| Q2 2015 | $291,000 | +14.6% | 96,200 | +11.9% | 0.02% | +9.1% |
| Q1 2015 | $254,000 | +156.6% | 86,000 | +285.7% | 0.02% | +144.4% |
| Q4 2014 | $99,000 | -35.3% | 22,300 | -25.2% | 0.01% | -35.7% |
| Q3 2014 | $153,000 | – | 29,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |